3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
CNS
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Leukemia, Myeloid, Acute
8
Lymphoma, Non-Hodgkin
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, B-Cell
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Burkitt Lymphoma
6
Recurrence
5
Lymphoma, Follicular
5
Leukemia
5
Leukemia, B-Cell
4
Hematologic Neoplasms
4
Lymphoma
3
Multiple Myeloma
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Prolymphocytic, B-Cell
2
Leukemia, Myeloid
2
Stomach Neoplasms
1
Sarcoma, Synovial
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell
1
Interventions
venetoclax
27
Cyclophosphamide
18
Azacitidine
13
fludarabine
12
ibrutinib
10
Busulfan
10
fludarabine phosphate
9
Rituximab
8
Mycophenolic Acid
8
Methotrexate
8
Cytarabine
8
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
Clofarabine
7
Therapeutics
6
Melphalan
6
Antilymphocyte Serum
6
obinutuzumab
5
Tacrolimus
5
Surveys and Questionnaires
5
Stem Cell Transplantation
5
Mesna
5
Exercise
5
Cyclosporine
5
vosaroxin
4
trametinib
4
thymoglobulin
4
ruxolitinib
4
ponatinib
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Immunotherapy, Adoptive
×
Other hematologic neoplasm
×
Clear all
NCT04206943
2020-01-27
ISIKOK-19
Acibadem University
Phase 1/2
Unknown
24 enrolled